Neurala Biosciences is developing a portfolio of medicinal products combining DMT & harmala alkaloids for the treatment of major mental health disorders including addiction, trauma and mood disorders. Psychedelic therapies are emerging as a novel group of psychiatric medicines in the mental health armory, on the back of very encouraging data emerging from a growing number of clinical studies.